SCHEMBL5348395

SCHEMBL5348395

CCC1(C)CC(OC(=O)NC)C(C)C(C)(CC)N1OC(C)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.36
CYP3A4 P08684 8/20 0.34
CTSK P43235 8/20 0.34
TSHR P16473 6/20 0.34
CYP2C9 P11712 5/20 0.34
CYP2C19 P33261 4/20 0.34
CTSV O60911 4/20 0.34
CTSL P07711 4/20 0.34
CTSS P25774 4/20 0.34
CYP2D6 P10635 3/20 0.34
CYP1A2 P05177 3/20 0.34
ALDH1A1 P00352 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CTSB P07858 1/20 0.34
MAPK1 P28482 1/20 0.33
KMT2A Q03164 3/20 0.32
LMNA P02545 2/20 0.32
MEN1 O00255 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5345102 0.91 BCHE (0.37) BCHECYP3A4CTSKTSHRCYP2C9
SCHEMBL5337659 0.91 CTSK (0.37) BCHECYP3A4CTSKTSHRCYP2C9
SCHEMBL5342283 0.90 MAPK1 (0.40) BCHECTSKCTSVCTSLCTSS
SCHEMBL5340543 0.90 CYP3A4 (0.34) CYP3A4CTSKTSHRCYP2C9CYP2C19
SCHEMBL27570114 0.89 KMT2A (0.33) BCHECYP3A4CTSKTSHRCYP2C9
SCHEMBL886987 0.89 KMT2A (0.36) BCHECYP3A4CTSKTSHRCTSV
SCHEMBL14590794 0.88 KMT2A (0.34) CYP3A4CTSKTSHRCYP2C9CYP2C19
SCHEMBL5336900 0.88 BCHE (0.35) BCHECYP3A4CTSKCTSVCTSL
SCHEMBL27570117 0.88 CYP2D6 (0.33) CYP3A4CTSKCTSVCTSLCTSS
SCHEMBL5347094 0.87 ALDH1A1 (0.38) BCHEALDH1A1SMN1; SMN2MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6624306-B2 Stabilizer for addition polymer CIBA SPECIALTY CHEMICALS CORPORATION 2003-09-23 US claimed
US-20030065184-A1 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides CIBA SPECIALTY CHEMICALS CORP. 2003-04-03 US claimed
US-7160966-B2 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides CIBA SPECIALTY CHEMICALS CORP. (US) 2007-01-09 US disclosed
US-7160966-B2 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides CIBA SPECIALTY CHEMICALS CORP. (US) 2007-01-09 US disclosed
US-7160966-B2 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides CIBA SPECIALTY CHEMICALS CORP. (US) 2007-01-09 US disclosed
US-20050143539-A1 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides NESVADBA PETER (CH) 2005-06-30 US disclosed
US-6624306-B2 Stabilizer for addition polymer CIBA SPECIALTY CHEMICALS CORPORATION 2003-09-23 US disclosed
US-20030065184-A1 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides CIBA SPECIALTY CHEMICALS CORP. 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143539-A1 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides ALKBH2, NFE2L2, DPYSL2 BCHE 4189/4885CYP3A4 1111/4885CTSK 4787/4885
US-20030065184-A1 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides ALKBH2, NFE2L2, DPYSL2 BCHE 4189/4885CYP3A4 1111/4885CTSK 4787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.